Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urolog...
Saved in:
| Published in | European urology Vol. 65; no. 6; pp. 1140 - 1151 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Kidlington
Elsevier B.V
01.06.2014
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers.
To review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer.
The PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder, and kidney.
We summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research.
LncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers.
In this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function.
Long noncoding RNAs (lncRNAs) are an integral part of cellular signalling, controlling cellular proliferation, differentiation, and survival. The functional impairment of lncRNAs is associated with carcinogenesis and cancer progression in urologic and other malignancies. LncRNAs hold clinical potential as novel biomarkers and therapeutics. |
|---|---|
| AbstractList | Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers.
To review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer.
The PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder, and kidney.
We summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research.
LncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers.
In this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function.
Long noncoding RNAs (lncRNAs) are an integral part of cellular signalling, controlling cellular proliferation, differentiation, and survival. The functional impairment of lncRNAs is associated with carcinogenesis and cancer progression in urologic and other malignancies. LncRNAs hold clinical potential as novel biomarkers and therapeutics. Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers.CONTEXTGenomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers.To review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer.OBJECTIVETo review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer.The PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder, and kidney.EVIDENCE ACQUISITIONThe PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder, and kidney.We summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research.EVIDENCE SYNTHESISWe summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research.LncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers.CONCLUSIONSLncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers.In this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function.PATIENT SUMMARYIn this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function. Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers. To review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer. The PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder, and kidney. We summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research. LncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers. In this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function. Context Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers. Objective: To review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer. Evidence acquisition The PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder, and kidney. Evidence synthesis We summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research. Conclusions: LncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers. Patient summary: In this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function. Abstract Context Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all cellular processes. Research over the last 10 yr has accumulated evidence that long noncoding RNAs (lncRNAs) are often altered in human urologic cancers. Objective To review current progress in the biology and implication of lncRNAs associated with prostate, bladder, and kidney cancer. Evidence acquisition The PubMed database was searched for articles in the English language with combinations of the Medical Subject Headings terms long non coding RNA, long noncoding RNA, long untranslated RNA, cancer, neoplasms, prostate, bladder , and kidney. Evidence synthesis We summarise existing knowledge on the systematics, biology, and function of lncRNAs, particularly these involved in prostate, kidney, and bladder cancer. We also discuss the possible utilisation of lncRNAs as novel biomarkers and potential therapeutic targets in urologic malignancies and portray the major challenges and future perspectives of ongoing lncRNA research. Conclusions LncRNAs are important regulators of gene expression interacting with the major pathways of cell growth, proliferation, differentiation, and survival. Alterations in the function of lncRNAs promote tumour formation, progression, and metastasis of prostate, bladder, and kidney cancer. LncRNAs can be used as noninvasive tumour markers in urologic malignancies. Increased knowledge of the molecular mechanisms by which lncRNAs perform their function in the normal and malignant cell will lead to a better understanding of tumour biology and could provide novel therapeutic targets for the treatment of urologic cancers. Patient summary In this paper we reviewed current knowledge of long noncoding RNAs (lncRNAs) for the detection and treatment of urologic cancers. We conclude that lncRNAs can be used as novel biomarkers in prostate, kidney, or bladder cancer. LncRNAs hold promise as future therapeutic targets, but more research is needed to gain a better understanding of their biologic function. |
| Author | Jenster, Guido Croce, Carlo M. Martens-Uzunova, Elena S. Visakorpi, Tapio Böttcher, René Calin, George A. |
| Author_xml | – sequence: 1 givenname: Elena S. surname: Martens-Uzunova fullname: Martens-Uzunova, Elena S. email: e.martens@erasmusmc.nl organization: Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands – sequence: 2 givenname: René surname: Böttcher fullname: Böttcher, René organization: Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands – sequence: 3 givenname: Carlo M. surname: Croce fullname: Croce, Carlo M. organization: Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA – sequence: 4 givenname: Guido surname: Jenster fullname: Jenster, Guido organization: Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands – sequence: 5 givenname: Tapio surname: Visakorpi fullname: Visakorpi, Tapio organization: Institute of Medical Technology, University of Tampere, Tampere University Hospital, Tampere, Finland – sequence: 6 givenname: George A. surname: Calin fullname: Calin, George A. organization: Department of Experimental Therapeutics and Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28441815$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24373479$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVkkuLFDEUhYOMOD2t_0CkNoKLqTLPqmQYhLHxhc0oPtYhndyStNXJmFQJ_e9N0T0IgoyuchffOeGec8_QSYgBEHpMcEMwaZ9vG5jSlGJDMWENoQ3G7B5aENmxuhMtPkELzDCtqWTyFJ3lvMWFEIo9QKeUs47xTi3QxTqGb9V1DDY6X6ZP11eVD9XHFPNoRjivXg7GOUjnlQmueu9dgH21MsFCeoju92bI8Oj4LtHX16--rN7W6w9v3q2u1rUVjI01ZQKkUI5YKQBTgVsGLVV0o2RrHe34BhNFlNhwoKIH0UpMqCOdpdz2TGC2RM8Ovjcp_pggj3rns4VhMAHilDURnJfVFG__AWWUS6oUL-iTIzptduD0TfI7k_b6NpoCPD0CJlsz9Kks7fNvTnJOZDFcoosDZ0tmOUGvrS_R-RjGZPygCdZzX3qrD33puS9NqC5tFDH_Q3zrf4fsxUEGJfefHpLO1kMpxfkEdtQu-v81sIMPvuz5HfaQt3FKoXSqic5FoD_PlzQfEmHFhPI5ncu_G9z9_y-Yy9V4 |
| CODEN | EUURAV |
| CitedBy_id | crossref_primary_10_1007_s12253_019_00614_3 crossref_primary_10_1038_s41585_019_0195_1 crossref_primary_10_1007_s12032_016_0841_x crossref_primary_10_18632_oncotarget_23147 crossref_primary_10_1080_21691401_2019_1575840 crossref_primary_10_1038_s41420_022_00956_z crossref_primary_10_1186_s12943_016_0574_7 crossref_primary_10_1002_cam4_4167 crossref_primary_10_1007_s10565_021_09650_9 crossref_primary_10_2147_CMAR_S244123 crossref_primary_10_1016_j_abb_2016_09_014 crossref_primary_10_1177_15330338221097215 crossref_primary_10_1111_iep_12305 crossref_primary_10_3389_fonc_2021_643163 crossref_primary_10_1016_j_ejso_2018_01_013 crossref_primary_10_1016_j_cca_2023_117305 crossref_primary_10_29254_2077_4214_2019_2_1_150_109_112 crossref_primary_10_1007_s13277_015_4445_4 crossref_primary_10_1016_j_metabol_2018_08_002 crossref_primary_10_18632_aging_202553 crossref_primary_10_3389_fgene_2019_01125 crossref_primary_10_3892_mmr_2016_4894 crossref_primary_10_1007_s11255_017_1536_8 crossref_primary_10_1002_jcp_30259 crossref_primary_10_1097_HCO_0000000000000107 crossref_primary_10_3389_fimmu_2021_706936 crossref_primary_10_3390_cancers12082148 crossref_primary_10_4103_1735_5362_323916 crossref_primary_10_1007_s10238_025_01618_x crossref_primary_10_1016_j_omtn_2021_01_025 crossref_primary_10_1186_s12943_017_0709_5 crossref_primary_10_3390_cells12081159 crossref_primary_10_18632_oncotarget_11391 crossref_primary_10_3389_fonc_2021_679244 crossref_primary_10_1038_s41419_022_04846_1 crossref_primary_10_1016_j_virusres_2016_06_008 crossref_primary_10_1016_j_prp_2024_155570 crossref_primary_10_1038_srep35421 crossref_primary_10_3892_ijo_2018_4395 crossref_primary_10_3892_mmr_2015_4711 crossref_primary_10_1155_2022_3299336 crossref_primary_10_1038_s41598_023_46484_3 crossref_primary_10_1152_ajprenal_00254_2019 crossref_primary_10_3389_fmolb_2021_654718 crossref_primary_10_3389_fcell_2020_00637 crossref_primary_10_1002_jcp_29025 crossref_primary_10_1158_1055_9965_EPI_14_0377 crossref_primary_10_1186_s12943_019_0942_1 crossref_primary_10_1155_2022_3729069 crossref_primary_10_1002_ijc_32827 crossref_primary_10_3389_fcell_2021_649605 crossref_primary_10_18632_oncotarget_23154 crossref_primary_10_3390_ijms222212516 crossref_primary_10_1097_MD_0000000000007084 crossref_primary_10_1038_s41388_020_1365_6 crossref_primary_10_1002_jcb_25862 crossref_primary_10_1586_14737159_2015_1019477 crossref_primary_10_1038_s41598_021_00364_w crossref_primary_10_1186_s12859_020_03868_w crossref_primary_10_1002_jcb_25987 crossref_primary_10_1002_jcb_25867 crossref_primary_10_1002_jcb_25988 crossref_primary_10_1089_cbr_2019_3059 crossref_primary_10_18632_oncotarget_2879 crossref_primary_10_1080_15384101_2020_1850971 crossref_primary_10_1089_cbr_2019_3177 crossref_primary_10_2147_OTT_S249770 crossref_primary_10_1177_03936155221077121 crossref_primary_10_1016_j_biopha_2017_11_055 crossref_primary_10_3892_mmr_2018_9491 crossref_primary_10_3389_fimmu_2024_1471198 crossref_primary_10_3389_fgene_2020_570325 crossref_primary_10_35995_tmj20200206 crossref_primary_10_1002_jcp_29470 crossref_primary_10_1038_srep37982 crossref_primary_10_1177_09603271211038744 crossref_primary_10_3390_ncrna4010007 crossref_primary_10_1002_advs_202303473 crossref_primary_10_1186_s12935_022_02490_5 crossref_primary_10_3390_ijms18071514 crossref_primary_10_1186_s12935_020_01654_5 crossref_primary_10_1002_jcb_26889 crossref_primary_10_1002_jcb_27857 crossref_primary_10_1007_s13277_016_4808_5 crossref_primary_10_1186_s12935_019_1073_x crossref_primary_10_1016_j_cellsig_2024_111525 crossref_primary_10_3389_fgene_2018_00422 crossref_primary_10_1089_hum_2017_256 crossref_primary_10_1016_j_mgene_2022_101024 crossref_primary_10_3390_cancers12051200 crossref_primary_10_1210_endocr_bqaa065 crossref_primary_10_1111_jcmm_15609 crossref_primary_10_1002_jcp_28037 crossref_primary_10_1002_jcp_28158 crossref_primary_10_1016_j_bbrc_2018_02_070 crossref_primary_10_1093_bfgp_ely031 crossref_primary_10_3390_cancers15041007 crossref_primary_10_1002_cam4_3046 crossref_primary_10_1111_boc_201400097 crossref_primary_10_1038_s41419_025_07456_9 crossref_primary_10_1089_dna_2017_3941 crossref_primary_10_1158_0008_5472_CAN_14_2931 crossref_primary_10_1016_j_semcancer_2020_10_001 crossref_primary_10_18632_aging_103718 crossref_primary_10_1089_dna_2019_4882 crossref_primary_10_3389_fphys_2019_00888 crossref_primary_10_3389_fonc_2020_00705 crossref_primary_10_1093_bioinformatics_btac518 crossref_primary_10_1016_j_biopha_2018_03_077 crossref_primary_10_1016_j_clgc_2022_02_005 crossref_primary_10_1093_jnen_nlaa129 crossref_primary_10_3390_cancers12040771 crossref_primary_10_3389_fonc_2019_01542 crossref_primary_10_1002_jcb_26865 crossref_primary_10_1111_crj_12906 crossref_primary_10_1016_j_clinbiochem_2019_02_013 crossref_primary_10_1021_acs_jproteome_8b00189 crossref_primary_10_1016_j_mce_2021_111350 crossref_primary_10_1371_journal_pone_0164590 crossref_primary_10_3389_fonc_2021_719855 crossref_primary_10_3892_ijmm_2023_5282 crossref_primary_10_3390_ijms17040573 crossref_primary_10_1002_jcp_28012 crossref_primary_10_1111_jcmm_13522 crossref_primary_10_3233_cbm_190246 crossref_primary_10_1016_j_febslet_2015_01_013 crossref_primary_10_3727_096504018X15152085755247 crossref_primary_10_3892_or_2024_8844 crossref_primary_10_1186_s12885_018_4863_y crossref_primary_10_1186_s12935_020_01412_7 crossref_primary_10_3892_mmr_2015_4503 crossref_primary_10_1089_dna_2021_0637 crossref_primary_10_1186_s12943_020_01153_1 crossref_primary_10_18632_oncotarget_17872 crossref_primary_10_3390_cancers13246247 crossref_primary_10_3389_fgene_2021_755706 crossref_primary_10_1186_s12935_020_01362_0 crossref_primary_10_1007_s11356_018_1678_y crossref_primary_10_1016_j_abb_2017_05_001 crossref_primary_10_1002_jcb_26442 crossref_primary_10_1016_j_gene_2019_100014 crossref_primary_10_1080_21691401_2019_1699815 crossref_primary_10_18632_oncotarget_19727 crossref_primary_10_1098_rsob_190068 crossref_primary_10_1177_1724600817747524 crossref_primary_10_18632_aging_103091 crossref_primary_10_18632_oncotarget_16693 crossref_primary_10_1016_j_eururo_2017_10_034 crossref_primary_10_18632_aging_104162 crossref_primary_10_1016_j_eururo_2020_05_022 crossref_primary_10_1038_s41598_017_00327_0 crossref_primary_10_3349_ymj_2020_61_3_210 crossref_primary_10_3389_fonc_2022_876531 crossref_primary_10_1007_s11010_020_03889_2 crossref_primary_10_3389_fonc_2020_624752 crossref_primary_10_1002_jcb_26336 crossref_primary_10_1002_jcb_26578 crossref_primary_10_18632_aging_204227 crossref_primary_10_18632_oncotarget_14149 crossref_primary_10_1002_jcb_26217 crossref_primary_10_1097_FJC_0000000000001259 crossref_primary_10_1080_00365521_2017_1392597 crossref_primary_10_1038_s41419_022_04996_2 crossref_primary_10_3892_ol_2019_10990 crossref_primary_10_34172_ajmb_2019_06 crossref_primary_10_1097_MOU_0000000000000090 crossref_primary_10_1016_j_ymthe_2017_06_027 crossref_primary_10_3892_ol_2019_10758 crossref_primary_10_1042_BSR20182498 crossref_primary_10_1016_j_canlet_2016_04_030 crossref_primary_10_2147_CMAR_S281920 crossref_primary_10_3389_fcell_2022_882698 crossref_primary_10_1080_15384101_2017_1288324 crossref_primary_10_1016_j_tranon_2020_100947 crossref_primary_10_2139_ssrn_4163710 crossref_primary_10_1016_j_omtn_2022_01_018 crossref_primary_10_1016_j_yexmp_2018_11_010 crossref_primary_10_1017_erm_2021_17 crossref_primary_10_1016_j_biopha_2018_01_105 crossref_primary_10_1136_jclinpath_2014_202658 crossref_primary_10_1093_jmcb_mjz058 crossref_primary_10_2147_PGPM_S449101 crossref_primary_10_3233_CBM_160635 crossref_primary_10_1002_jbt_23441 crossref_primary_10_3389_fonc_2021_726745 crossref_primary_10_1089_dna_2019_4834 crossref_primary_10_1186_s12935_021_02114_4 crossref_primary_10_3390_diagnostics8040068 crossref_primary_10_1016_j_canlet_2016_12_005 crossref_primary_10_1016_j_bbrc_2016_01_056 crossref_primary_10_1007_s10330_021_0486_6 crossref_primary_10_3389_fcell_2021_746714 crossref_primary_10_1007_s00216_018_1424_9 crossref_primary_10_1155_2019_8265958 crossref_primary_10_1158_1078_0432_CCR_14_0706 crossref_primary_10_1186_s12935_020_01383_9 crossref_primary_10_1007_s13402_023_00826_5 crossref_primary_10_1039_C8RA09546A crossref_primary_10_1016_j_yexcr_2017_09_037 crossref_primary_10_1111_jcmm_14102 crossref_primary_10_18632_aging_102911 crossref_primary_10_1039_D2MO00107A crossref_primary_10_1002_jgm_3344 crossref_primary_10_1016_j_biopha_2017_10_083 crossref_primary_10_1038_emm_2017_223 crossref_primary_10_18632_oncotarget_15047 crossref_primary_10_1038_s41598_023_31424_y crossref_primary_10_18632_oncotarget_21719 crossref_primary_10_1155_2021_4338838 crossref_primary_10_3389_fgene_2019_00113 crossref_primary_10_1007_s11010_020_03868_7 crossref_primary_10_1042_BSR20193153 crossref_primary_10_1111_jcmm_16537 crossref_primary_10_1155_2021_8849977 crossref_primary_10_3390_ijms18040740 crossref_primary_10_1016_j_tranon_2020_100974 crossref_primary_10_1155_2021_9972454 crossref_primary_10_1016_j_genrep_2018_03_002 crossref_primary_10_1111_jcmm_16894 crossref_primary_10_3389_fgene_2020_604655 crossref_primary_10_1093_bib_bbw060 crossref_primary_10_1155_2022_7346460 crossref_primary_10_1002_jgm_3210 crossref_primary_10_1016_j_cbi_2021_109396 crossref_primary_10_1016_j_ncrna_2020_04_003 crossref_primary_10_2217_nnm_2021_0249 crossref_primary_10_3389_fphar_2020_00164 crossref_primary_10_1097_MD_0000000000034130 crossref_primary_10_3233_CBM_191026 crossref_primary_10_1155_2021_1683129 crossref_primary_10_1093_jb_mvz108 crossref_primary_10_2217_epi_2020_0270 crossref_primary_10_12677_ACM_2023_132267 crossref_primary_10_1038_s41419_019_2077_0 crossref_primary_10_3390_cancers11121840 crossref_primary_10_1186_s12943_017_0644_5 crossref_primary_10_3389_fcell_2021_777349 crossref_primary_10_3892_ol_2019_10684 crossref_primary_10_1155_2021_5568411 crossref_primary_10_1016_j_jnutbio_2017_01_001 crossref_primary_10_18632_oncotarget_21614 crossref_primary_10_1186_s13046_019_1193_0 crossref_primary_10_1016_S1872_2040_17_61067_3 crossref_primary_10_1002_jcb_26231 crossref_primary_10_1016_j_urolonc_2015_06_003 crossref_primary_10_1016_j_eururo_2018_03_005 crossref_primary_10_1373_clinchem_2014_230359 crossref_primary_10_1002_jcb_27327 crossref_primary_10_1007_s13577_019_00287_9 crossref_primary_10_1093_bfgp_elv059 crossref_primary_10_1155_2020_6634247 crossref_primary_10_1097_MD_0000000000027222 crossref_primary_10_3389_fcell_2021_623809 crossref_primary_10_1038_s41417_024_00834_z crossref_primary_10_1002_iid3_817 crossref_primary_10_1186_s13046_022_02467_2 crossref_primary_10_1016_j_omtn_2019_06_008 crossref_primary_10_3892_ol_2019_10808 crossref_primary_10_18632_oncotarget_10752 crossref_primary_10_7717_peerj_5124 crossref_primary_10_1002_EXP_20230126 crossref_primary_10_1155_2022_8131007 crossref_primary_10_3389_fonc_2021_710767 crossref_primary_10_1186_s12935_019_0794_1 crossref_primary_10_1016_j_bbrc_2016_09_028 crossref_primary_10_1038_s41419_021_04406_z crossref_primary_10_1016_j_genrep_2020_101013 crossref_primary_10_18632_oncotarget_16284 crossref_primary_10_3892_ol_2019_10700 crossref_primary_10_1360_SSV_2024_0099 crossref_primary_10_1530_REP_19_0005 crossref_primary_10_18632_aging_103355 crossref_primary_10_3892_etm_2024_12777 crossref_primary_10_32948_auo_2022_11_24 crossref_primary_10_1007_s00345_022_03996_3 crossref_primary_10_1002_jbt_23381 crossref_primary_10_1042_BSR20181644 crossref_primary_10_1038_s41374_021_00577_7 crossref_primary_10_1038_s41420_021_00419_x crossref_primary_10_3389_fgene_2022_821675 crossref_primary_10_1042_BSR20180562 crossref_primary_10_3892_or_2017_5840 crossref_primary_10_3389_fgene_2022_854211 crossref_primary_10_1016_j_heliyon_2024_e38342 crossref_primary_10_1016_j_lfs_2018_01_025 crossref_primary_10_1158_0008_5472_CAN_16_2634 crossref_primary_10_1007_s13577_022_00725_1 crossref_primary_10_1002_jcb_26021 crossref_primary_10_2217_epi_2020_0101 crossref_primary_10_3892_ijmm_2019_4444 crossref_primary_10_7717_peerj_7522 crossref_primary_10_1007_s12038_018_9820_z crossref_primary_10_3389_fgene_2019_00828 crossref_primary_10_1002_jcla_24036 crossref_primary_10_1002_cbf_3531 crossref_primary_10_1186_s12967_022_03711_1 crossref_primary_10_1002_jcp_28832 crossref_primary_10_1039_C6MB00359A crossref_primary_10_1038_s41598_019_44944_3 crossref_primary_10_1038_s41388_021_02033_8 crossref_primary_10_1016_j_prp_2023_154998 crossref_primary_10_1038_s41419_021_04296_1 crossref_primary_10_18632_oncotarget_12937 crossref_primary_10_1002_jcb_26395 crossref_primary_10_1371_journal_pgen_1007001 crossref_primary_10_1186_s12885_021_08981_4 crossref_primary_10_1371_journal_pone_0117873 crossref_primary_10_1016_j_taap_2015_09_016 crossref_primary_10_2147_OTT_S288785 crossref_primary_10_1042_BSR20170301 crossref_primary_10_1155_2022_3546795 crossref_primary_10_1016_j_juro_2016_05_107 crossref_primary_10_1111_cpr_12615 crossref_primary_10_1139_bcb_2018_0313 crossref_primary_10_1038_srep30798 crossref_primary_10_1016_j_ncrna_2017_06_003 crossref_primary_10_1097_CEJ_0000000000000571 crossref_primary_10_7717_peerj_10149 crossref_primary_10_1155_2021_7952922 crossref_primary_10_1155_2020_2016259 crossref_primary_10_2147_CMAR_S265545 crossref_primary_10_1038_s41467_018_06152_x crossref_primary_10_1097_MD_0000000000036026 crossref_primary_10_1155_2020_4830847 crossref_primary_10_1038_onc_2016_356 crossref_primary_10_1158_1541_7786_MCR_17_0776 crossref_primary_10_3389_fgene_2019_00751 crossref_primary_10_1097_WNR_0000000000001538 crossref_primary_10_1186_s12885_018_4461_z crossref_primary_10_18632_aging_102185 crossref_primary_10_1038_s41598_020_77252_2 crossref_primary_10_1016_j_abb_2017_01_013 crossref_primary_10_2147_IJGM_S354682 crossref_primary_10_1080_14737159_2020_1699791 crossref_primary_10_3389_fcell_2020_624764 crossref_primary_10_1016_j_prp_2020_152851 crossref_primary_10_1002_mgg3_1349 crossref_primary_10_1055_a_1745_8952 crossref_primary_10_3892_ijo_2017_4173 crossref_primary_10_1093_jjco_hyv214 crossref_primary_10_3389_fonc_2021_650287 crossref_primary_10_18632_oncotarget_12960 crossref_primary_10_18632_aging_204263 crossref_primary_10_1007_s00120_014_3655_5 crossref_primary_10_1016_j_semcancer_2021_06_023 crossref_primary_10_1007_s12079_021_00645_z crossref_primary_10_1080_09168451_2017_1387048 crossref_primary_10_18632_oncotarget_22555 crossref_primary_10_3389_fphar_2024_1442227 crossref_primary_10_5582_bst_2016_01140 crossref_primary_10_1016_j_yexcr_2020_111839 crossref_primary_10_1016_j_ncrna_2021_08_001 crossref_primary_10_2147_OTT_S245537 crossref_primary_10_1139_bcb_2019_0300 crossref_primary_10_2147_OTT_S252195 crossref_primary_10_3390_ncrna7020025 crossref_primary_10_1155_2015_319861 crossref_primary_10_3390_cancers12010235 crossref_primary_10_3892_or_2017_5751 crossref_primary_10_3389_fcell_2021_705291 crossref_primary_10_1080_14737159_2020_1822169 crossref_primary_10_1016_j_biopha_2017_06_089 crossref_primary_10_1080_21691401_2020_1773487 crossref_primary_10_1089_cbr_2019_3300 crossref_primary_10_1016_j_omtn_2018_05_018 crossref_primary_10_1097_FJC_0000000000001074 crossref_primary_10_2147_CMAR_S264682 crossref_primary_10_1089_dna_2019_5282 crossref_primary_10_1007_s13273_023_00391_w crossref_primary_10_1016_j_actbio_2023_06_011 crossref_primary_10_1038_s41419_020_03171_9 crossref_primary_10_18632_oncotarget_21693 crossref_primary_10_18632_oncotarget_10444 crossref_primary_10_1016_j_ebiom_2018_07_014 crossref_primary_10_1096_fj_201900078RR crossref_primary_10_1186_s12935_020_01715_9 crossref_primary_10_1186_s13578_017_0193_z crossref_primary_10_1016_j_currproblcancer_2014_11_004 crossref_primary_10_1155_2017_3859582 crossref_primary_10_2174_1389557521666211101161548 crossref_primary_10_1002_cam4_1979 crossref_primary_10_1007_s13277_015_4159_7 crossref_primary_10_1016_j_bcp_2023_115572 crossref_primary_10_1159_000529947 crossref_primary_10_3390_ijms23020628 crossref_primary_10_1080_15384047_2018_1423912 crossref_primary_10_4103_jss_jss_77_21 crossref_primary_10_1002_jcb_25910 crossref_primary_10_2174_0929867330666230306143351 crossref_primary_10_1186_s12935_020_1126_1 crossref_primary_10_1016_j_pharmthera_2022_108188 crossref_primary_10_1016_j_mam_2024_101280 crossref_primary_10_1155_2021_8171250 crossref_primary_10_18632_aging_102424 crossref_primary_10_1111_cas_14074 crossref_primary_10_3892_or_2017_5445 crossref_primary_10_1038_s41419_018_0264_z crossref_primary_10_2174_1566524023666230724141353 crossref_primary_10_1016_j_synbio_2016_08_001 crossref_primary_10_3892_ol_2021_13013 crossref_primary_10_1016_j_abb_2016_12_011 crossref_primary_10_1002_jcb_29370 crossref_primary_10_1016_j_oooo_2016_10_006 crossref_primary_10_1038_s41388_018_0643_z crossref_primary_10_3389_fonc_2018_00362 crossref_primary_10_3892_or_2021_8115 crossref_primary_10_3390_ijms21176087 crossref_primary_10_1186_s12935_020_01467_6 crossref_primary_10_18632_oncotarget_15703 crossref_primary_10_1155_2020_8884450 crossref_primary_10_1016_j_biopha_2018_08_105 crossref_primary_10_3390_genes8110339 crossref_primary_10_1002_jcp_27483 crossref_primary_10_3389_fonc_2022_930923 crossref_primary_10_1002_path_6325 crossref_primary_10_18632_oncotarget_14726 crossref_primary_10_3727_096504017X14920318811721 crossref_primary_10_3892_ijo_2019_4937 crossref_primary_10_1186_s12935_016_0356_8 crossref_primary_10_1038_srep39516 crossref_primary_10_1186_s13046_016_0397_9 crossref_primary_10_3389_fgene_2020_562967 crossref_primary_10_4111_icu_20210194 crossref_primary_10_2147_OTT_S284167 crossref_primary_10_3389_fonc_2022_924072 crossref_primary_10_3892_ijo_2015_3177 crossref_primary_10_1016_j_biopha_2019_109255 crossref_primary_10_1089_dna_2016_3553 crossref_primary_10_31491_CSRC_2018_9_022 crossref_primary_10_1016_j_yexcr_2018_11_005 crossref_primary_10_18632_aging_102591 crossref_primary_10_1186_s12943_019_1021_3 crossref_primary_10_3892_ol_2018_8825 crossref_primary_10_1038_s41420_021_00709_4 crossref_primary_10_1007_s11010_021_04250_x crossref_primary_10_1007_s12672_024_01564_2 crossref_primary_10_1007_s00018_018_2877_x crossref_primary_10_1007_s13577_021_00563_7 crossref_primary_10_1016_j_omto_2021_11_005 crossref_primary_10_18632_oncotarget_14510 crossref_primary_10_3389_fonc_2019_01008 crossref_primary_10_1186_s13148_015_0047_7 crossref_primary_10_18632_oncotarget_24307 crossref_primary_10_1038_s41598_024_82425_4 crossref_primary_10_1186_s12943_018_0880_3 crossref_primary_10_1111_jcmm_13940 crossref_primary_10_1186_s13046_017_0519_z crossref_primary_10_1109_JBHI_2019_2958389 crossref_primary_10_1186_s12943_017_0737_1 crossref_primary_10_1042_BSR20180400 crossref_primary_10_1016_j_biopha_2018_07_129 crossref_primary_10_1089_cbr_2019_3119 crossref_primary_10_3389_fgene_2022_952369 crossref_primary_10_1016_j_eururo_2014_01_032 crossref_primary_10_1111_cns_13121 crossref_primary_10_1002_cai2_156 crossref_primary_10_1155_2022_2754836 crossref_primary_10_2298_GENSR2203147M crossref_primary_10_2147_OTT_S232965 crossref_primary_10_1007_s10565_020_09524_6 crossref_primary_10_1590_1414_431x20198883 crossref_primary_10_1016_j_exer_2022_109340 crossref_primary_10_1007_s13577_019_00303_y crossref_primary_10_2174_1568009620666210106122421 crossref_primary_10_1016_j_biopha_2018_09_181 crossref_primary_10_1002_jcb_28089 crossref_primary_10_1016_j_cclet_2021_07_048 crossref_primary_10_3390_cancers14164059 crossref_primary_10_3389_fonc_2022_856560 crossref_primary_10_1007_s11010_019_03565_0 crossref_primary_10_3389_fonc_2019_01266 crossref_primary_10_2147_CMAR_S297842 crossref_primary_10_3892_ol_2022_13190 crossref_primary_10_1002_jcp_28517 crossref_primary_10_1038_s41419_018_0275_9 crossref_primary_10_1177_1758835920927850 crossref_primary_10_1139_bcb_2018_0168 crossref_primary_10_1166_jbt_2023_3259 crossref_primary_10_1186_s12935_017_0478_7 crossref_primary_10_2174_1874609815666220126095847 crossref_primary_10_1371_journal_pone_0176287 crossref_primary_10_1042_BSR20181627 crossref_primary_10_2217_fon_2019_0538 crossref_primary_10_2147_CMAR_S249582 crossref_primary_10_3389_fonc_2022_847745 crossref_primary_10_18632_aging_205056 crossref_primary_10_1038_s41598_018_20727_0 |
| Cites_doi | 10.1074/jbc.M405015200 10.1093/hmg/ddl001 10.1002/elps.200600852 10.1038/nature09144 10.1038/nature09819 10.1016/j.molcel.2008.08.022 10.1016/j.cell.2011.07.014 10.1016/0014-5793(95)01074-O 10.1210/mend.16.3.0787 10.1039/c2mb25386k 10.1073/pnas.97.22.12216 10.1016/j.cell.2011.08.054 10.1126/scisignal.2000568 10.1038/nature11993 10.1016/j.eururo.2008.01.060 10.1038/ncb2521 10.1093/hmg/8.7.1209 10.1038/349038a0 10.1093/hmg/ddr419 10.1038/nmeth.1573 10.1002/mc.10075 10.1371/journal.pone.0000845 10.3727/096504005776404607 10.1093/hmg/ddg178 10.1038/cgt.2012.10 10.1186/1476-4598-12-13 10.1128/MCB.10.1.28 10.1016/S0140-6736(03)15170-7 10.1038/sj.onc.1201742 10.1074/jbc.M702029200 10.1007/s00439-013-1308-1 10.1038/nature11233 10.1016/j.gene.2012.01.012 10.1016/j.molcel.2012.07.033 10.2174/187221509789318360 10.1158/1078-0432.CCR-06-0134 10.1007/s00268-010-0951-0 10.1038/pcan.2013.6 10.1074/jbc.274.41.29331 10.1039/c2mb25070e 10.1002/jso.23264 10.1038/sj.onc.1207069 10.1038/nbt.1914 10.1038/nature11247 10.1016/j.urology.2012.08.044 10.1038/nsmb.2480 10.1038/nature11362 10.1093/nar/gks071 10.1073/pnas.0904715106 10.1093/carcin/bgr187 10.1016/j.nbt.2012.11.012 10.1093/carcin/bgs140 10.1158/0008-5472.CAN-08-1714 10.3390/molecules15085460 10.1038/nature11928 10.1038/nature08975 10.1016/0092-8674(93)90279-Y 10.1016/j.cdp.2008.12.002 10.1016/j.juro.2012.07.023 10.1016/j.ccr.2013.04.025 10.1007/s00018-012-1080-8 10.1016/j.molcel.2010.12.011 10.1158/0008-5472.CAN-06-0037 10.1186/1479-7364-5-2-90 10.4161/cc.10.18.17183 10.1530/JME-12-0008 10.1136/mp.53.6.320 10.1038/nsmb.2516 10.1111/j.1349-7006.2010.01737.x 10.1093/hmg/10.23.2619 10.1073/pnas.0931430100 10.1016/j.urolonc.2011.11.030 10.1038/nature11884 10.1089/dna.2006.25.135 10.1016/j.canlet.2013.01.033 10.1093/jnci/91.2.143 10.1038/onc.2011.304 10.1186/1479-5876-8-134 10.1093/hmg/11.13.1527 10.5483/BMBRep.2013.46.2.016 10.1038/cr.2012.30 10.1038/nature09744 10.1111/febs.12185 10.1038/emboj.2013.99 10.1016/j.cell.2011.09.029 10.1128/MCB.18.12.6897 10.1038/nature12451 10.1016/j.febslet.2008.05.012 10.1101/gr.132159.111 10.7314/APJCP.2013.14.2.1077 10.1038/ng.848 10.1038/sj.onc.1206928 10.1126/scisignal.2000594 10.1016/j.ccr.2007.07.027 10.1016/j.urology.2010.09.022 10.1038/sj.onc.1209846 10.1038/nature10006 10.1016/j.canlet.2012.11.058 |
| ContentType | Journal Article |
| Copyright | 2013 European Association of Urology European Association of Urology 2015 INIST-CNRS Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2013 European Association of Urology – notice: European Association of Urology – notice: 2015 INIST-CNRS – notice: Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TM |
| DOI | 10.1016/j.eururo.2013.12.003 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Nucleic Acids Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Nucleic Acids Abstracts |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Nucleic Acids Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-7560 |
| EndPage | 1151 |
| ExternalDocumentID | 24373479 28441815 10_1016_j_eururo_2013_12_003 S0302283813013249 1_s2_0_S0302283813013249 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0~B 1B1 1P~ 1~. 1~5 29G 30W 34G 39C 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 8UI AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYIC AAYWO ABBQC ABBTS ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWCG ABWVN ABXDB ACDAQ ACIEU ACQXL ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEYAO AFJKZ AFPUW AFRHN AFSIO AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CAG COF CS3 CYUIP DU5 E0A EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FB. FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O1H O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 RKO ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UJ6 UV1 X7M Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU AZPMC EFLBG LCYCR ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TM |
| ID | FETCH-LOGICAL-c533t-235e859d1c85e025063e6292b986cd274b019195b4e25fe568012d17c24cf3503 |
| IEDL.DBID | .~1 |
| ISSN | 0302-2838 1873-7560 |
| IngestDate | Fri Jul 11 11:53:44 EDT 2025 Fri Jul 11 00:57:51 EDT 2025 Thu Apr 03 07:08:43 EDT 2025 Wed Apr 02 07:35:49 EDT 2025 Tue Jul 01 02:35:20 EDT 2025 Thu Apr 24 23:04:55 EDT 2025 Fri Feb 23 02:16:45 EST 2024 Sun Feb 23 10:18:58 EST 2025 Tue Aug 26 17:11:58 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Wilms tumour Beckwith-Wiedemann syndrome lncRNA Renal cell carcinoma Kidney cancer Long noncoding RNA Urothelial carcinoma Bladder cancer Prostate cancer Nephrology Prostate disease RNA Non coding sequence IncRNA Transitional cell carcinoma Urology Wilms tumor Grawitz tumor Male genital diseases Kidney disease Urinary system disease Urinary tract disease Malignant tumor Congenital disease Genetic disease Abdominal disease Bladder disease Cancer |
| Language | English |
| License | CC BY 4.0 Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c533t-235e859d1c85e025063e6292b986cd274b019195b4e25fe568012d17c24cf3503 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 24373479 |
| PQID | 1532482994 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_1544000946 proquest_miscellaneous_1532482994 pubmed_primary_24373479 pascalfrancis_primary_28441815 crossref_citationtrail_10_1016_j_eururo_2013_12_003 crossref_primary_10_1016_j_eururo_2013_12_003 elsevier_sciencedirect_doi_10_1016_j_eururo_2013_12_003 elsevier_clinicalkeyesjournals_1_s2_0_S0302283813013249 elsevier_clinicalkey_doi_10_1016_j_eururo_2013_12_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-06-01 |
| PublicationDateYYYYMMDD | 2014-06-01 |
| PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: Switzerland |
| PublicationTitle | European urology |
| PublicationTitleAlternate | Eur Urol |
| PublicationYear | 2014 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Weakley, Wang, Yao, Chen (bib0065) 2011; 35 Ying, Chen, Wang, Zhou, Huang, Qiu (bib0300) 2012; 8 Mastroyiannopoulos, Uney, Phylactou (bib0445) 2010; 15 Luo, Li, Wang, Zeng, Liu, Qiu (bib0235) 2013; 280 Chung, Nakagawa, Uemura (bib0100) 2011; 102 Elkin, Shevelev, Schulze (bib0020) 1995; 374 Ren, Peng, Mao (bib0060) 2012; 22 Ariel, Sughayer, Fellig (bib0415) 2000; 53 Han, Liu, Gui, Cai (bib0325) 2013; 107 Dunham, Kundaje, Aldred (bib0005) 2012; 489 Iorio, Croce (bib0125) 2012; 33 Pandey, Mondal, Mohammad (bib0200) 2008; 32 Norris, Fan, Sherk, McDonnell (bib0180) 2002; 16 Poliseno, Salmena, Zhang, Carver, Haveman, Pandolfi (bib0140) 2010; 465 Martens-Uzunova, Olvedy, Jenster (bib0050) 2013; 340 Kawakami, Okamoto, Ogawa, Okada (bib0375) 2004; 363 Keniry, Oxley, Monnier (bib0185) 2012; 14 Davis, Hsi, Arroyo (bib0310) 2003; 100 Fu, Dobosy, Desotelle (bib0220) 2008; 68 Lin, Maeda, Liu, Karin, Edgington (bib0305) 2006; 26 Crawford, Rove, Trabulsi (bib0370) 2012; 188 Dugimont, Montpellier, Adriaenssens (bib0245) 1998; 16 Luo, Li, Wang, Zeng, Liu, Qiu (bib0230) 2013; 333 Wang, Li, Xie, Zhao, Chen (bib0335) 2008; 582 Zhou, Zhong, Wang (bib0260) 2007; 282 Han, Liu, Nie, Gui, Cai (bib0295) 2013; 81 McGinn, Gut (bib0475) 2013; 30 Yang, Li, Wang, Zhao, Chen (bib0345) 2012; 496 Martens-Uzunova, Jalava, Dits (bib0190) 2012; 31 Srikantan, Zou, Petrovics (bib0085) 2000; 97 Hanna, Ohana, Konikoff (bib0450) 2012; 19 Yang, Lin, Liu (bib0320) 2011; 147 Barsyte-Lovejoy, Lau, Boutros (bib0240) 2006; 66 Brown, Ballabio, Rupert (bib0025) 1991; 349 Thrash-Bingham, Tartof (bib0405) 1999; 91 Wheeler, Leger, Pandey (bib0440) 2012; 488 Zhu, Yu, Li (bib0400) 2011; 77 Fu, Ravindranath, Tran, Petrovics, Srivastava (bib0095) 2006; 25 Zhou, Zhang, Klibanski (bib0265) 2012; 48 Khalil, Guttman, Huarte (bib0075) 2009; 106 Petrovics, Zhang, Makarem (bib0090) 2004; 23 Wright, Bruford (bib0045) 2011; 5 Johnsson, Ackley, Vidarsdottir (bib0145) 2013; 20 Hung, Wang, Lin (bib0435) 2011; 43 Prensner, Iyer, Balbin (bib0055) 2011; 29 Derrien, Johnson, Bussotti (bib0040) 2012; 22 Bussemakers, van Bokhoven, Verhaegh (bib0035) 1999; 59 Teles Alves, Hiltemann, Hartjes (bib0465) 2013; 132 Song, Park, Jeong, Park, Kang, Lee (bib0385) 2007; 28 Cavaille, Seitz, Paulsen, Ferguson-Smith, Bachellerie (bib0285) 2002; 11 Ifere, Ananaba (bib0390) 2009; 3 Kwon (bib0480) 2013; 46 Ayesh, Matouk, Schneider (bib0250) 2002; 35 Matouk, DeGroot, Mezan (bib0255) 2007; 2 Lai, Orom, Cesaroni (bib0120) 2013; 494 Shen (bib0470) 2013; 23 Capel, Swain, Nicolis (bib0155) 1993; 73 Smith, Steitz (bib0030) 1998; 18 Ying, Huang, Chen (bib0270) 2013; 9 Fu, Schwarze, Kenowski, Leblanc, Svaren, Jarrard (bib0215) 2004; 279 Itzkovitz, van Oudenaarden (bib0485) 2011; 8 Takai, Gonzales, Tsai, Thayer, Jones (bib0225) 2001; 10 Mercer, Mattick (bib0495) 2013; 20 Mitsuya, Meguro, Lee (bib0195) 1999; 8 Salmena, Poliseno, Tay, Kats, Pandolfi (bib0130) 2011; 146 Tay, Kats, Salmena (bib0150) 2011; 147 Kino, Hurt, Ichijo, Nader, Chrousos (bib0170) 2010; 3 Cui, Ren, Lu (bib0350) 2013; 31 Novikova, Hennelly, Sanbonmatsu (bib0490) 2012; 40 Ji, Diederichs, Wang (bib0290) 2003; 22 Chiesa, De Crescenzo, Mishra (bib0205) 2012; 21 Yang, Lin, Jin (bib0105) 2013; 500 Amit, Hochberg (bib0455) 2010; 8 Takayama, Horie-Inoue, Katayama (bib0355) 2013; 32 Memczak, Jens, Elefsinioti (bib0165) 2013; 495 Benetatos, Hatzimichael, Londin (bib0280) 2013; 70 Qiao, Gao, Huo, Yang (bib0500) 2013; 14 Frevel, Sowerby, Petersen, Reeve (bib0210) 1999; 274 Berger, Lawrence, Demichelis (bib0460) 2011; 470 Hudson, Yi, Volfovsky (bib0365) 2013; 12 Yin, Yang, Zhang (bib0175) 2012; 48 Kawakami, Chano, Minami, Okabe, Okada, Okamoto (bib0275) 2006; 15 Bertozzi, Iurlaro, Sordet, Marinello, Zaffaroni, Capranico (bib0410) 2011; 10 Verhaegh, Verkleij, Vermeulen, den Heijer, Witjes, Kiemeney (bib0425) 2008; 54 Laner, Schulz, Engers, Muller, Florl (bib0380) 2005; 15 Jin, Sun, Isaacs (bib0420) 2011; 32 Xue, Wang, Kang (bib0430) 2013; 16 Zhao, Ohsumi, Kung (bib0080) 2010; 40 Wang, Yang, Liu (bib0115) 2011; 472 Wang, Zhang, Wang (bib0330) 2006; 12 Wang, Garcia-Bassets, Benner (bib0110) 2011; 474 Ifere, Barr, Equan (bib0395) 2009; 32 Brannan, Dees, Ingram, Tilghman (bib0015) 1990; 10 Poliseno, Salmena, Riccardi (bib0135) 2010; 3 Calin, Liu, Ferracin (bib0360) 2007; 12 Gupta, Shah, Wang (bib0070) 2010; 464 Wang, Chen, Yang (bib0340) 2012; 41 Djebali, Davis, Merkel (bib0010) 2012; 489 Hansen, Jensen, Clausen (bib0160) 2013; 495 Kuiper, Schepens, Thijssen (bib0315) 2003; 12 Zhu (10.1016/j.eururo.2013.12.003_bib0400) 2011; 77 Barsyte-Lovejoy (10.1016/j.eururo.2013.12.003_bib0240) 2006; 66 Derrien (10.1016/j.eururo.2013.12.003_bib0040) 2012; 22 Davis (10.1016/j.eururo.2013.12.003_bib0310) 2003; 100 Fu (10.1016/j.eururo.2013.12.003_bib0220) 2008; 68 Wang (10.1016/j.eururo.2013.12.003_bib0110) 2011; 474 Benetatos (10.1016/j.eururo.2013.12.003_bib0280) 2013; 70 Mercer (10.1016/j.eururo.2013.12.003_bib0495) 2013; 20 Brannan (10.1016/j.eururo.2013.12.003_bib0015) 1990; 10 Johnsson (10.1016/j.eururo.2013.12.003_bib0145) 2013; 20 Khalil (10.1016/j.eururo.2013.12.003_bib0075) 2009; 106 Zhou (10.1016/j.eururo.2013.12.003_bib0265) 2012; 48 Berger (10.1016/j.eururo.2013.12.003_bib0460) 2011; 470 Song (10.1016/j.eururo.2013.12.003_bib0385) 2007; 28 Bertozzi (10.1016/j.eururo.2013.12.003_bib0410) 2011; 10 Cavaille (10.1016/j.eururo.2013.12.003_bib0285) 2002; 11 Yin (10.1016/j.eururo.2013.12.003_bib0175) 2012; 48 Memczak (10.1016/j.eururo.2013.12.003_bib0165) 2013; 495 Keniry (10.1016/j.eururo.2013.12.003_bib0185) 2012; 14 Ji (10.1016/j.eururo.2013.12.003_bib0290) 2003; 22 Matouk (10.1016/j.eururo.2013.12.003_bib0255) 2007; 2 Zhao (10.1016/j.eururo.2013.12.003_bib0080) 2010; 40 Elkin (10.1016/j.eururo.2013.12.003_bib0020) 1995; 374 Wang (10.1016/j.eururo.2013.12.003_bib0340) 2012; 41 Tay (10.1016/j.eururo.2013.12.003_bib0150) 2011; 147 Luo (10.1016/j.eururo.2013.12.003_bib0235) 2013; 280 Wang (10.1016/j.eururo.2013.12.003_bib0330) 2006; 12 Shen (10.1016/j.eururo.2013.12.003_bib0470) 2013; 23 Kino (10.1016/j.eururo.2013.12.003_bib0170) 2010; 3 Takai (10.1016/j.eururo.2013.12.003_bib0225) 2001; 10 Lin (10.1016/j.eururo.2013.12.003_bib0305) 2006; 26 Wright (10.1016/j.eururo.2013.12.003_bib0045) 2011; 5 Novikova (10.1016/j.eururo.2013.12.003_bib0490) 2012; 40 Weakley (10.1016/j.eururo.2013.12.003_bib0065) 2011; 35 Crawford (10.1016/j.eururo.2013.12.003_bib0370) 2012; 188 Jin (10.1016/j.eururo.2013.12.003_bib0420) 2011; 32 Mastroyiannopoulos (10.1016/j.eururo.2013.12.003_bib0445) 2010; 15 Zhou (10.1016/j.eururo.2013.12.003_bib0260) 2007; 282 Kwon (10.1016/j.eururo.2013.12.003_bib0480) 2013; 46 Kawakami (10.1016/j.eururo.2013.12.003_bib0275) 2006; 15 Luo (10.1016/j.eururo.2013.12.003_bib0230) 2013; 333 Salmena (10.1016/j.eururo.2013.12.003_bib0130) 2011; 146 Hung (10.1016/j.eururo.2013.12.003_bib0435) 2011; 43 Iorio (10.1016/j.eururo.2013.12.003_bib0125) 2012; 33 Ayesh (10.1016/j.eururo.2013.12.003_bib0250) 2002; 35 Ariel (10.1016/j.eururo.2013.12.003_bib0415) 2000; 53 Mitsuya (10.1016/j.eururo.2013.12.003_bib0195) 1999; 8 Cui (10.1016/j.eururo.2013.12.003_bib0350) 2013; 31 Qiao (10.1016/j.eururo.2013.12.003_bib0500) 2013; 14 Ren (10.1016/j.eururo.2013.12.003_bib0060) 2012; 22 Norris (10.1016/j.eururo.2013.12.003_bib0180) 2002; 16 Ying (10.1016/j.eururo.2013.12.003_bib0300) 2012; 8 McGinn (10.1016/j.eururo.2013.12.003_bib0475) 2013; 30 Yang (10.1016/j.eururo.2013.12.003_bib0320) 2011; 147 Srikantan (10.1016/j.eururo.2013.12.003_bib0085) 2000; 97 Capel (10.1016/j.eururo.2013.12.003_bib0155) 1993; 73 Verhaegh (10.1016/j.eururo.2013.12.003_bib0425) 2008; 54 Martens-Uzunova (10.1016/j.eururo.2013.12.003_bib0190) 2012; 31 Wheeler (10.1016/j.eururo.2013.12.003_bib0440) 2012; 488 Ifere (10.1016/j.eururo.2013.12.003_bib0390) 2009; 3 Hansen (10.1016/j.eururo.2013.12.003_bib0160) 2013; 495 Hanna (10.1016/j.eururo.2013.12.003_bib0450) 2012; 19 Chung (10.1016/j.eururo.2013.12.003_bib0100) 2011; 102 Brown (10.1016/j.eururo.2013.12.003_bib0025) 1991; 349 Thrash-Bingham (10.1016/j.eururo.2013.12.003_bib0405) 1999; 91 Ying (10.1016/j.eururo.2013.12.003_bib0270) 2013; 9 Smith (10.1016/j.eururo.2013.12.003_bib0030) 1998; 18 Dugimont (10.1016/j.eururo.2013.12.003_bib0245) 1998; 16 Hudson (10.1016/j.eururo.2013.12.003_bib0365) 2013; 12 Ifere (10.1016/j.eururo.2013.12.003_bib0395) 2009; 32 Poliseno (10.1016/j.eururo.2013.12.003_bib0140) 2010; 465 Xue (10.1016/j.eururo.2013.12.003_bib0430) 2013; 16 Djebali (10.1016/j.eururo.2013.12.003_bib0010) 2012; 489 Kawakami (10.1016/j.eururo.2013.12.003_bib0375) 2004; 363 Fu (10.1016/j.eururo.2013.12.003_bib0215) 2004; 279 Chiesa (10.1016/j.eururo.2013.12.003_bib0205) 2012; 21 Laner (10.1016/j.eururo.2013.12.003_bib0380) 2005; 15 Dunham (10.1016/j.eururo.2013.12.003_bib0005) 2012; 489 Gupta (10.1016/j.eururo.2013.12.003_bib0070) 2010; 464 Frevel (10.1016/j.eururo.2013.12.003_bib0210) 1999; 274 Petrovics (10.1016/j.eururo.2013.12.003_bib0090) 2004; 23 Teles Alves (10.1016/j.eururo.2013.12.003_bib0465) 2013; 132 Kuiper (10.1016/j.eururo.2013.12.003_bib0315) 2003; 12 Pandey (10.1016/j.eururo.2013.12.003_bib0200) 2008; 32 Han (10.1016/j.eururo.2013.12.003_bib0295) 2013; 81 Martens-Uzunova (10.1016/j.eururo.2013.12.003_bib0050) 2013; 340 Han (10.1016/j.eururo.2013.12.003_bib0325) 2013; 107 Fu (10.1016/j.eururo.2013.12.003_bib0095) 2006; 25 Lai (10.1016/j.eururo.2013.12.003_bib0120) 2013; 494 Prensner (10.1016/j.eururo.2013.12.003_bib0055) 2011; 29 Yang (10.1016/j.eururo.2013.12.003_bib0345) 2012; 496 Itzkovitz (10.1016/j.eururo.2013.12.003_bib0485) 2011; 8 Calin (10.1016/j.eururo.2013.12.003_bib0360) 2007; 12 Amit (10.1016/j.eururo.2013.12.003_bib0455) 2010; 8 Bussemakers (10.1016/j.eururo.2013.12.003_bib0035) 1999; 59 Wang (10.1016/j.eururo.2013.12.003_bib0115) 2011; 472 Yang (10.1016/j.eururo.2013.12.003_bib0105) 2013; 500 Poliseno (10.1016/j.eururo.2013.12.003_bib0135) 2010; 3 Wang (10.1016/j.eururo.2013.12.003_bib0335) 2008; 582 Takayama (10.1016/j.eururo.2013.12.003_bib0355) 2013; 32 24508069 - Eur Urol. 2014 Jun;65(6):1152-3 |
| References_xml | – volume: 333 start-page: 213 year: 2013 end-page: 221 ident: bib0230 article-title: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression publication-title: Cancer Lett – volume: 31 start-page: 978 year: 2012 end-page: 991 ident: bib0190 article-title: Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer publication-title: Oncogene – volume: 500 start-page: 598 year: 2013 end-page: 602 ident: bib0105 article-title: lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs publication-title: Nature – volume: 35 start-page: 63 year: 2002 end-page: 74 ident: bib0250 article-title: Possible physiological role of H19 RNA publication-title: Mol Carcinog – volume: 32 start-page: 1655 year: 2011 end-page: 1659 ident: bib0420 article-title: Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk publication-title: Carcinogenesis – volume: 464 start-page: 1071 year: 2010 end-page: 1076 ident: bib0070 article-title: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis publication-title: Nature – volume: 106 start-page: 11667 year: 2009 end-page: 11672 ident: bib0075 article-title: Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression publication-title: Proc Natl Acad Sci U S A – volume: 16 start-page: 2395 year: 1998 end-page: 2401 ident: bib0245 article-title: The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53 publication-title: Oncogene – volume: 91 start-page: 143 year: 1999 end-page: 151 ident: bib0405 article-title: aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia publication-title: J Natl Cancer Inst – volume: 48 start-page: R45 year: 2012 end-page: R53 ident: bib0265 article-title: MEG3 noncoding RNA: a tumor suppressor publication-title: J Mol Endocrinol – volume: 22 start-page: 806 year: 2012 end-page: 821 ident: bib0060 article-title: RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings publication-title: Cell Res – volume: 15 start-page: 5460 year: 2010 end-page: 5472 ident: bib0445 article-title: The application of ribozymes and DNAzymes in muscle and brain publication-title: Molecules – volume: 8 start-page: S12 year: 2011 end-page: S19 ident: bib0485 article-title: Validating transcripts with probes and imaging technology publication-title: Nat Methods – volume: 10 start-page: 2619 year: 2001 end-page: 2626 ident: bib0225 article-title: Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer publication-title: Hum Mol Genet – volume: 349 start-page: 38 year: 1991 end-page: 44 ident: bib0025 article-title: A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome publication-title: Nature – volume: 282 start-page: 24731 year: 2007 end-page: 24742 ident: bib0260 article-title: Activation of p53 by MEG3 non-coding RNA publication-title: J Biol Chem – volume: 46 start-page: 65 year: 2013 end-page: 72 ident: bib0480 article-title: Single-molecule fluorescence in situ hybridization: quantitative imaging of single RNA molecules publication-title: BMB Rep – volume: 30 start-page: 366 year: 2013 end-page: 372 ident: bib0475 article-title: DNA sequencing—spanning the generations publication-title: N Biotechnol – volume: 32 start-page: 1665 year: 2013 end-page: 1680 ident: bib0355 article-title: Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer publication-title: Embo J – volume: 9 start-page: 407 year: 2013 end-page: 411 ident: bib0270 article-title: Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer publication-title: Mol Biosyst – volume: 14 start-page: 659 year: 2012 end-page: 665 ident: bib0185 article-title: The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r publication-title: Nat Cell Biol – volume: 3 start-page: 151 year: 2009 end-page: 163 ident: bib0390 article-title: Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression publication-title: Recent Pat DNA Gene Seq – volume: 8 start-page: 1209 year: 1999 end-page: 1217 ident: bib0195 article-title: LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids publication-title: Hum Mol Genet – volume: 147 start-page: 773 year: 2011 end-page: 788 ident: bib0320 article-title: ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs publication-title: Cell – volume: 32 start-page: 232 year: 2008 end-page: 246 ident: bib0200 article-title: Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation publication-title: Mol Cell – volume: 59 start-page: 5975 year: 1999 end-page: 5979 ident: bib0035 article-title: DD3: a new prostate-specific gene, highly overexpressed in prostate cancer publication-title: Cancer Res – volume: 12 start-page: 4851 year: 2006 end-page: 4858 ident: bib0330 article-title: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma publication-title: Clin Cancer Res – volume: 12 start-page: 13 year: 2013 ident: bib0365 article-title: Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer publication-title: Mol Cancer – volume: 32 start-page: 319 year: 2009 end-page: 328 ident: bib0395 article-title: Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines publication-title: Cancer Detect Prev – volume: 16 start-page: 139 year: 2013 end-page: 144 ident: bib0430 article-title: Association between lncrna PCGEM1 polymorphisms and prostate cancer risk publication-title: Prostate Cancer Prostatic Dis – volume: 97 start-page: 12216 year: 2000 end-page: 12221 ident: bib0085 article-title: PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer publication-title: Proc Natl Acad Sci U S A – volume: 40 start-page: 5034 year: 2012 end-page: 5051 ident: bib0490 article-title: Structural architecture of the human long non-coding RNA, steroid receptor RNA activator publication-title: Nucleic Acids Res – volume: 25 start-page: 135 year: 2006 end-page: 141 ident: bib0095 article-title: Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1 publication-title: DNA Cell Biol – volume: 488 start-page: 111 year: 2012 end-page: 115 ident: bib0440 article-title: Targeting nuclear RNA for in vivo correction of myotonic dystrophy publication-title: Nature – volume: 3 start-page: ra29 year: 2010 ident: bib0135 article-title: Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation publication-title: Sci Signal – volume: 23 start-page: 567 year: 2013 end-page: 569 ident: bib0470 article-title: Chromoplexy: a new category of complex rearrangements in the cancer genome publication-title: Cancer Cell – volume: 23 start-page: 605 year: 2004 end-page: 611 ident: bib0090 article-title: Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients publication-title: Oncogene – volume: 495 start-page: 333 year: 2013 end-page: 338 ident: bib0165 article-title: Circular RNAs are a large class of animal RNAs with regulatory potency publication-title: Nature – volume: 68 start-page: 6797 year: 2008 end-page: 6802 ident: bib0220 article-title: Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate publication-title: Cancer Res – volume: 22 start-page: 1775 year: 2012 end-page: 1789 ident: bib0040 article-title: The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression publication-title: Genome Res – volume: 489 start-page: 57 year: 2012 end-page: 74 ident: bib0005 article-title: An integrated encyclopedia of DNA elements in the human genome publication-title: Nature – volume: 40 start-page: 939 year: 2010 end-page: 953 ident: bib0080 article-title: Genome-wide identification of polycomb-associated RNAs by RIP-seq publication-title: Mol Cell – volume: 14 start-page: 1077 year: 2013 end-page: 1082 ident: bib0500 article-title: Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma publication-title: Asian Pac J Cancer Prev – volume: 472 start-page: 120 year: 2011 end-page: 124 ident: bib0115 article-title: A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression publication-title: Nature – volume: 8 start-page: 2289 year: 2012 end-page: 2294 ident: bib0300 article-title: Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition publication-title: Mol Biosyst – volume: 340 start-page: 201 year: 2013 end-page: 211 ident: bib0050 article-title: Beyond microRNA—novel RNAs derived from small non-coding RNA and their implication in cancer publication-title: Cancer Lett – volume: 77 year: 2011 ident: bib0400 article-title: ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival publication-title: Urology – volume: 15 start-page: 821 year: 2006 end-page: 830 ident: bib0275 article-title: Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma publication-title: Hum Mol Genet – volume: 22 start-page: 8031 year: 2003 end-page: 8041 ident: bib0290 article-title: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer publication-title: Oncogene – volume: 12 start-page: 1661 year: 2003 end-page: 1669 ident: bib0315 article-title: Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution publication-title: Hum Mol Genet – volume: 582 start-page: 1919 year: 2008 end-page: 1927 ident: bib0335 article-title: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion publication-title: FEBS Lett – volume: 12 start-page: 215 year: 2007 end-page: 229 ident: bib0360 article-title: Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas publication-title: Cancer Cell – volume: 107 start-page: 555 year: 2013 end-page: 559 ident: bib0325 article-title: Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder publication-title: J Surg Oncol – volume: 470 start-page: 214 year: 2011 end-page: 220 ident: bib0460 article-title: The genomic complexity of primary human prostate cancer publication-title: Nature – volume: 18 start-page: 6897 year: 1998 end-page: 6909 ident: bib0030 article-title: Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes publication-title: Mol Cell Biol – volume: 280 start-page: 1709 year: 2013 end-page: 1716 ident: bib0235 article-title: Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression publication-title: Febs J – volume: 73 start-page: 1019 year: 1993 end-page: 1030 ident: bib0155 article-title: Circular transcripts of the testis-determining gene Sry in adult mouse testis publication-title: Cell – volume: 496 start-page: 8 year: 2012 end-page: 16 ident: bib0345 article-title: Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells publication-title: Gene – volume: 2 start-page: e845 year: 2007 ident: bib0255 article-title: The H19 non-coding RNA is essential for human tumor growth publication-title: PLoS One – volume: 81 year: 2013 ident: bib0295 article-title: Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder publication-title: Urology – volume: 279 start-page: 52218 year: 2004 end-page: 52226 ident: bib0215 article-title: A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells publication-title: J Biol Chem – volume: 494 start-page: 497 year: 2013 end-page: 501 ident: bib0120 article-title: Activating RNAs associate with Mediator to enhance chromatin architecture and transcription publication-title: Nature – volume: 8 start-page: 134 year: 2010 ident: bib0455 article-title: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences publication-title: J Transl Med – volume: 35 start-page: 1751 year: 2011 end-page: 1756 ident: bib0065 article-title: Expression and function of a large non-coding RNA gene XIST in human cancer publication-title: World J Surg – volume: 11 start-page: 1527 year: 2002 end-page: 1538 ident: bib0285 article-title: Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region publication-title: Hum Mol Genet – volume: 33 start-page: 1126 year: 2012 end-page: 1133 ident: bib0125 article-title: microRNA involvement in human cancer publication-title: Carcinogenesis – volume: 19 start-page: 374 year: 2012 end-page: 381 ident: bib0450 article-title: Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer publication-title: Cancer Gene Ther – volume: 54 start-page: 1118 year: 2008 end-page: 1126 ident: bib0425 article-title: Polymorphisms in the H19 gene and the risk of bladder cancer publication-title: Eur Urol – volume: 29 start-page: 742 year: 2011 end-page: 749 ident: bib0055 article-title: Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression publication-title: Nat Biotechnol – volume: 26 start-page: 851 year: 2006 end-page: 858 ident: bib0305 article-title: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas publication-title: Oncogene – volume: 41 start-page: 276 year: 2012 end-page: 284 ident: bib0340 article-title: Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer publication-title: Int J Oncol – volume: 10 start-page: 3189 year: 2011 end-page: 3197 ident: bib0410 article-title: Characterization of novel antisense HIF-1alpha transcripts in human cancers publication-title: Cell Cycle – volume: 16 start-page: 459 year: 2002 end-page: 468 ident: bib0180 article-title: A negative coregulator for the human ER publication-title: Mol Endocrinol – volume: 10 start-page: 28 year: 1990 end-page: 36 ident: bib0015 article-title: The product of the H19 gene may function as an RNA publication-title: Mol Cell Biol – volume: 100 start-page: 6051 year: 2003 end-page: 6056 ident: bib0310 article-title: Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation publication-title: Proc Natl Acad Sci U S A – volume: 21 start-page: 10 year: 2012 end-page: 25 ident: bib0205 article-title: The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases publication-title: Hum Mol Genet – volume: 70 start-page: 795 year: 2013 end-page: 814 ident: bib0280 article-title: The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis publication-title: Cell Mol Life Sci – volume: 146 start-page: 353 year: 2011 end-page: 358 ident: bib0130 article-title: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? publication-title: Cell – volume: 48 start-page: 219 year: 2012 end-page: 230 ident: bib0175 article-title: Long noncoding RNAs with snoRNA ends publication-title: Mol Cell – volume: 66 start-page: 5330 year: 2006 end-page: 5337 ident: bib0240 article-title: The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis publication-title: Cancer Res – volume: 20 start-page: 440 year: 2013 end-page: 446 ident: bib0145 article-title: A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells publication-title: Nat Struct Mol Biol – volume: 465 start-page: 1033 year: 2010 end-page: 1038 ident: bib0140 article-title: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology publication-title: Nature – volume: 5 start-page: 90 year: 2011 end-page: 98 ident: bib0045 article-title: Naming ‘junk’: human non-protein coding RNA (ncRNA) gene nomenclature publication-title: Hum Genomics – volume: 274 start-page: 29331 year: 1999 end-page: 29340 ident: bib0210 article-title: Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor publication-title: J Biol Chem – volume: 43 start-page: 621 year: 2011 end-page: 629 ident: bib0435 article-title: Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters publication-title: Nat Genet – volume: 147 start-page: 344 year: 2011 end-page: 357 ident: bib0150 article-title: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs publication-title: Cell – volume: 188 start-page: 1726 year: 2012 end-page: 1731 ident: bib0370 article-title: Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases publication-title: J Urol – volume: 3 start-page: ra8 year: 2010 ident: bib0170 article-title: Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor publication-title: Sci Signal – volume: 53 start-page: 320 year: 2000 end-page: 323 ident: bib0415 article-title: The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma publication-title: Mol Pathol – volume: 474 start-page: 390 year: 2011 end-page: 394 ident: bib0110 article-title: Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA publication-title: Nature – volume: 28 start-page: 2379 year: 2007 end-page: 2384 ident: bib0385 article-title: Quantification of CpG methylation at the 5′-region of XIST by pyrosequencing from human serum publication-title: Electrophoresis – volume: 374 start-page: 57 year: 1995 end-page: 61 ident: bib0020 article-title: The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma publication-title: FEBS Lett – volume: 31 start-page: 1117 year: 2013 end-page: 1123 ident: bib0350 article-title: The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor publication-title: Urol Oncol – volume: 363 start-page: 40 year: 2004 end-page: 42 ident: bib0375 article-title: XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer publication-title: Lancet – volume: 132 start-page: 709 year: 2013 end-page: 713 ident: bib0465 article-title: Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line publication-title: Hum Genet – volume: 489 start-page: 101 year: 2012 end-page: 108 ident: bib0010 article-title: Landscape of transcription in human cells publication-title: Nature – volume: 495 start-page: 384 year: 2013 end-page: 388 ident: bib0160 article-title: Natural RNA circles function as efficient microRNA sponges publication-title: Nature – volume: 102 start-page: 245 year: 2011 end-page: 252 ident: bib0100 article-title: Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility publication-title: Cancer Sci – volume: 20 start-page: 300 year: 2013 end-page: 307 ident: bib0495 article-title: Structure and function of long noncoding RNAs in epigenetic regulation publication-title: Nat Struct Mol Biol – volume: 15 start-page: 257 year: 2005 end-page: 264 ident: bib0380 article-title: Hypomethylation of the XIST gene promoter in prostate cancer publication-title: Oncol Res – volume: 279 start-page: 52218 year: 2004 ident: 10.1016/j.eururo.2013.12.003_bib0215 article-title: A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells publication-title: J Biol Chem doi: 10.1074/jbc.M405015200 – volume: 15 start-page: 821 year: 2006 ident: 10.1016/j.eururo.2013.12.003_bib0275 article-title: Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma publication-title: Hum Mol Genet doi: 10.1093/hmg/ddl001 – volume: 28 start-page: 2379 year: 2007 ident: 10.1016/j.eururo.2013.12.003_bib0385 article-title: Quantification of CpG methylation at the 5′-region of XIST by pyrosequencing from human serum publication-title: Electrophoresis doi: 10.1002/elps.200600852 – volume: 465 start-page: 1033 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0140 article-title: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology publication-title: Nature doi: 10.1038/nature09144 – volume: 472 start-page: 120 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0115 article-title: A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression publication-title: Nature doi: 10.1038/nature09819 – volume: 32 start-page: 232 year: 2008 ident: 10.1016/j.eururo.2013.12.003_bib0200 article-title: Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation publication-title: Mol Cell doi: 10.1016/j.molcel.2008.08.022 – volume: 146 start-page: 353 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0130 article-title: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? publication-title: Cell doi: 10.1016/j.cell.2011.07.014 – volume: 374 start-page: 57 year: 1995 ident: 10.1016/j.eururo.2013.12.003_bib0020 article-title: The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma publication-title: FEBS Lett doi: 10.1016/0014-5793(95)01074-O – volume: 16 start-page: 459 year: 2002 ident: 10.1016/j.eururo.2013.12.003_bib0180 article-title: A negative coregulator for the human ER publication-title: Mol Endocrinol doi: 10.1210/mend.16.3.0787 – volume: 9 start-page: 407 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0270 article-title: Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer publication-title: Mol Biosyst doi: 10.1039/c2mb25386k – volume: 97 start-page: 12216 year: 2000 ident: 10.1016/j.eururo.2013.12.003_bib0085 article-title: PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.97.22.12216 – volume: 147 start-page: 773 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0320 article-title: ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs publication-title: Cell doi: 10.1016/j.cell.2011.08.054 – volume: 3 start-page: ra8 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0170 article-title: Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor publication-title: Sci Signal doi: 10.1126/scisignal.2000568 – volume: 495 start-page: 384 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0160 article-title: Natural RNA circles function as efficient microRNA sponges publication-title: Nature doi: 10.1038/nature11993 – volume: 54 start-page: 1118 year: 2008 ident: 10.1016/j.eururo.2013.12.003_bib0425 article-title: Polymorphisms in the H19 gene and the risk of bladder cancer publication-title: Eur Urol doi: 10.1016/j.eururo.2008.01.060 – volume: 14 start-page: 659 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0185 article-title: The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r publication-title: Nat Cell Biol doi: 10.1038/ncb2521 – volume: 8 start-page: 1209 year: 1999 ident: 10.1016/j.eururo.2013.12.003_bib0195 article-title: LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids publication-title: Hum Mol Genet doi: 10.1093/hmg/8.7.1209 – volume: 349 start-page: 38 year: 1991 ident: 10.1016/j.eururo.2013.12.003_bib0025 article-title: A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome publication-title: Nature doi: 10.1038/349038a0 – volume: 21 start-page: 10 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0205 article-title: The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr419 – volume: 8 start-page: S12 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0485 article-title: Validating transcripts with probes and imaging technology publication-title: Nat Methods doi: 10.1038/nmeth.1573 – volume: 35 start-page: 63 year: 2002 ident: 10.1016/j.eururo.2013.12.003_bib0250 article-title: Possible physiological role of H19 RNA publication-title: Mol Carcinog doi: 10.1002/mc.10075 – volume: 2 start-page: e845 year: 2007 ident: 10.1016/j.eururo.2013.12.003_bib0255 article-title: The H19 non-coding RNA is essential for human tumor growth publication-title: PLoS One doi: 10.1371/journal.pone.0000845 – volume: 15 start-page: 257 year: 2005 ident: 10.1016/j.eururo.2013.12.003_bib0380 article-title: Hypomethylation of the XIST gene promoter in prostate cancer publication-title: Oncol Res doi: 10.3727/096504005776404607 – volume: 12 start-page: 1661 year: 2003 ident: 10.1016/j.eururo.2013.12.003_bib0315 article-title: Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution publication-title: Hum Mol Genet doi: 10.1093/hmg/ddg178 – volume: 19 start-page: 374 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0450 article-title: Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer publication-title: Cancer Gene Ther doi: 10.1038/cgt.2012.10 – volume: 12 start-page: 13 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0365 article-title: Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer publication-title: Mol Cancer doi: 10.1186/1476-4598-12-13 – volume: 10 start-page: 28 year: 1990 ident: 10.1016/j.eururo.2013.12.003_bib0015 article-title: The product of the H19 gene may function as an RNA publication-title: Mol Cell Biol doi: 10.1128/MCB.10.1.28 – volume: 363 start-page: 40 year: 2004 ident: 10.1016/j.eururo.2013.12.003_bib0375 article-title: XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer publication-title: Lancet doi: 10.1016/S0140-6736(03)15170-7 – volume: 16 start-page: 2395 year: 1998 ident: 10.1016/j.eururo.2013.12.003_bib0245 article-title: The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53 publication-title: Oncogene doi: 10.1038/sj.onc.1201742 – volume: 282 start-page: 24731 year: 2007 ident: 10.1016/j.eururo.2013.12.003_bib0260 article-title: Activation of p53 by MEG3 non-coding RNA publication-title: J Biol Chem doi: 10.1074/jbc.M702029200 – volume: 132 start-page: 709 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0465 article-title: Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line publication-title: Hum Genet doi: 10.1007/s00439-013-1308-1 – volume: 489 start-page: 101 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0010 article-title: Landscape of transcription in human cells publication-title: Nature doi: 10.1038/nature11233 – volume: 496 start-page: 8 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0345 article-title: Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells publication-title: Gene doi: 10.1016/j.gene.2012.01.012 – volume: 48 start-page: 219 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0175 article-title: Long noncoding RNAs with snoRNA ends publication-title: Mol Cell doi: 10.1016/j.molcel.2012.07.033 – volume: 3 start-page: 151 year: 2009 ident: 10.1016/j.eururo.2013.12.003_bib0390 article-title: Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression publication-title: Recent Pat DNA Gene Seq doi: 10.2174/187221509789318360 – volume: 12 start-page: 4851 year: 2006 ident: 10.1016/j.eururo.2013.12.003_bib0330 article-title: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-0134 – volume: 35 start-page: 1751 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0065 article-title: Expression and function of a large non-coding RNA gene XIST in human cancer publication-title: World J Surg doi: 10.1007/s00268-010-0951-0 – volume: 16 start-page: 139 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0430 article-title: Association between lncrna PCGEM1 polymorphisms and prostate cancer risk publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/pcan.2013.6 – volume: 274 start-page: 29331 year: 1999 ident: 10.1016/j.eururo.2013.12.003_bib0210 article-title: Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor publication-title: J Biol Chem doi: 10.1074/jbc.274.41.29331 – volume: 8 start-page: 2289 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0300 article-title: Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition publication-title: Mol Biosyst doi: 10.1039/c2mb25070e – volume: 107 start-page: 555 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0325 article-title: Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder publication-title: J Surg Oncol doi: 10.1002/jso.23264 – volume: 23 start-page: 605 year: 2004 ident: 10.1016/j.eururo.2013.12.003_bib0090 article-title: Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients publication-title: Oncogene doi: 10.1038/sj.onc.1207069 – volume: 29 start-page: 742 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0055 article-title: Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression publication-title: Nat Biotechnol doi: 10.1038/nbt.1914 – volume: 489 start-page: 57 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0005 article-title: An integrated encyclopedia of DNA elements in the human genome publication-title: Nature doi: 10.1038/nature11247 – volume: 81 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0295 article-title: Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder publication-title: Urology doi: 10.1016/j.urology.2012.08.044 – volume: 20 start-page: 300 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0495 article-title: Structure and function of long noncoding RNAs in epigenetic regulation publication-title: Nat Struct Mol Biol doi: 10.1038/nsmb.2480 – volume: 59 start-page: 5975 year: 1999 ident: 10.1016/j.eururo.2013.12.003_bib0035 article-title: DD3: a new prostate-specific gene, highly overexpressed in prostate cancer publication-title: Cancer Res – volume: 488 start-page: 111 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0440 article-title: Targeting nuclear RNA for in vivo correction of myotonic dystrophy publication-title: Nature doi: 10.1038/nature11362 – volume: 40 start-page: 5034 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0490 article-title: Structural architecture of the human long non-coding RNA, steroid receptor RNA activator publication-title: Nucleic Acids Res doi: 10.1093/nar/gks071 – volume: 106 start-page: 11667 year: 2009 ident: 10.1016/j.eururo.2013.12.003_bib0075 article-title: Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0904715106 – volume: 32 start-page: 1655 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0420 article-title: Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk publication-title: Carcinogenesis doi: 10.1093/carcin/bgr187 – volume: 30 start-page: 366 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0475 article-title: DNA sequencing—spanning the generations publication-title: N Biotechnol doi: 10.1016/j.nbt.2012.11.012 – volume: 33 start-page: 1126 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0125 article-title: microRNA involvement in human cancer publication-title: Carcinogenesis doi: 10.1093/carcin/bgs140 – volume: 68 start-page: 6797 year: 2008 ident: 10.1016/j.eururo.2013.12.003_bib0220 article-title: Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-1714 – volume: 15 start-page: 5460 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0445 article-title: The application of ribozymes and DNAzymes in muscle and brain publication-title: Molecules doi: 10.3390/molecules15085460 – volume: 495 start-page: 333 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0165 article-title: Circular RNAs are a large class of animal RNAs with regulatory potency publication-title: Nature doi: 10.1038/nature11928 – volume: 464 start-page: 1071 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0070 article-title: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis publication-title: Nature doi: 10.1038/nature08975 – volume: 73 start-page: 1019 year: 1993 ident: 10.1016/j.eururo.2013.12.003_bib0155 article-title: Circular transcripts of the testis-determining gene Sry in adult mouse testis publication-title: Cell doi: 10.1016/0092-8674(93)90279-Y – volume: 32 start-page: 319 year: 2009 ident: 10.1016/j.eururo.2013.12.003_bib0395 article-title: Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines publication-title: Cancer Detect Prev doi: 10.1016/j.cdp.2008.12.002 – volume: 188 start-page: 1726 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0370 article-title: Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases publication-title: J Urol doi: 10.1016/j.juro.2012.07.023 – volume: 23 start-page: 567 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0470 article-title: Chromoplexy: a new category of complex rearrangements in the cancer genome publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.04.025 – volume: 70 start-page: 795 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0280 article-title: The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis publication-title: Cell Mol Life Sci doi: 10.1007/s00018-012-1080-8 – volume: 40 start-page: 939 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0080 article-title: Genome-wide identification of polycomb-associated RNAs by RIP-seq publication-title: Mol Cell doi: 10.1016/j.molcel.2010.12.011 – volume: 66 start-page: 5330 year: 2006 ident: 10.1016/j.eururo.2013.12.003_bib0240 article-title: The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0037 – volume: 5 start-page: 90 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0045 article-title: Naming ‘junk’: human non-protein coding RNA (ncRNA) gene nomenclature publication-title: Hum Genomics doi: 10.1186/1479-7364-5-2-90 – volume: 10 start-page: 3189 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0410 article-title: Characterization of novel antisense HIF-1alpha transcripts in human cancers publication-title: Cell Cycle doi: 10.4161/cc.10.18.17183 – volume: 48 start-page: R45 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0265 article-title: MEG3 noncoding RNA: a tumor suppressor publication-title: J Mol Endocrinol doi: 10.1530/JME-12-0008 – volume: 53 start-page: 320 year: 2000 ident: 10.1016/j.eururo.2013.12.003_bib0415 article-title: The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma publication-title: Mol Pathol doi: 10.1136/mp.53.6.320 – volume: 20 start-page: 440 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0145 article-title: A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells publication-title: Nat Struct Mol Biol doi: 10.1038/nsmb.2516 – volume: 102 start-page: 245 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0100 article-title: Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2010.01737.x – volume: 10 start-page: 2619 year: 2001 ident: 10.1016/j.eururo.2013.12.003_bib0225 article-title: Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer publication-title: Hum Mol Genet doi: 10.1093/hmg/10.23.2619 – volume: 100 start-page: 6051 year: 2003 ident: 10.1016/j.eururo.2013.12.003_bib0310 article-title: Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0931430100 – volume: 31 start-page: 1117 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0350 article-title: The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor publication-title: Urol Oncol doi: 10.1016/j.urolonc.2011.11.030 – volume: 494 start-page: 497 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0120 article-title: Activating RNAs associate with Mediator to enhance chromatin architecture and transcription publication-title: Nature doi: 10.1038/nature11884 – volume: 25 start-page: 135 year: 2006 ident: 10.1016/j.eururo.2013.12.003_bib0095 article-title: Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1 publication-title: DNA Cell Biol doi: 10.1089/dna.2006.25.135 – volume: 333 start-page: 213 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0230 article-title: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression publication-title: Cancer Lett doi: 10.1016/j.canlet.2013.01.033 – volume: 91 start-page: 143 year: 1999 ident: 10.1016/j.eururo.2013.12.003_bib0405 article-title: aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia publication-title: J Natl Cancer Inst doi: 10.1093/jnci/91.2.143 – volume: 31 start-page: 978 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0190 article-title: Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer publication-title: Oncogene doi: 10.1038/onc.2011.304 – volume: 8 start-page: 134 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0455 article-title: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences publication-title: J Transl Med doi: 10.1186/1479-5876-8-134 – volume: 11 start-page: 1527 year: 2002 ident: 10.1016/j.eururo.2013.12.003_bib0285 article-title: Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region publication-title: Hum Mol Genet doi: 10.1093/hmg/11.13.1527 – volume: 46 start-page: 65 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0480 article-title: Single-molecule fluorescence in situ hybridization: quantitative imaging of single RNA molecules publication-title: BMB Rep doi: 10.5483/BMBRep.2013.46.2.016 – volume: 22 start-page: 806 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0060 article-title: RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings publication-title: Cell Res doi: 10.1038/cr.2012.30 – volume: 470 start-page: 214 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0460 article-title: The genomic complexity of primary human prostate cancer publication-title: Nature doi: 10.1038/nature09744 – volume: 280 start-page: 1709 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0235 article-title: Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression publication-title: Febs J doi: 10.1111/febs.12185 – volume: 32 start-page: 1665 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0355 article-title: Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer publication-title: Embo J doi: 10.1038/emboj.2013.99 – volume: 147 start-page: 344 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0150 article-title: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs publication-title: Cell doi: 10.1016/j.cell.2011.09.029 – volume: 41 start-page: 276 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0340 article-title: Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer publication-title: Int J Oncol – volume: 18 start-page: 6897 year: 1998 ident: 10.1016/j.eururo.2013.12.003_bib0030 article-title: Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes publication-title: Mol Cell Biol doi: 10.1128/MCB.18.12.6897 – volume: 500 start-page: 598 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0105 article-title: lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs publication-title: Nature doi: 10.1038/nature12451 – volume: 582 start-page: 1919 year: 2008 ident: 10.1016/j.eururo.2013.12.003_bib0335 article-title: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion publication-title: FEBS Lett doi: 10.1016/j.febslet.2008.05.012 – volume: 22 start-page: 1775 year: 2012 ident: 10.1016/j.eururo.2013.12.003_bib0040 article-title: The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression publication-title: Genome Res doi: 10.1101/gr.132159.111 – volume: 14 start-page: 1077 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0500 article-title: Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2013.14.2.1077 – volume: 43 start-page: 621 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0435 article-title: Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters publication-title: Nat Genet doi: 10.1038/ng.848 – volume: 22 start-page: 8031 year: 2003 ident: 10.1016/j.eururo.2013.12.003_bib0290 article-title: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer publication-title: Oncogene doi: 10.1038/sj.onc.1206928 – volume: 3 start-page: ra29 year: 2010 ident: 10.1016/j.eururo.2013.12.003_bib0135 article-title: Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation publication-title: Sci Signal doi: 10.1126/scisignal.2000594 – volume: 12 start-page: 215 year: 2007 ident: 10.1016/j.eururo.2013.12.003_bib0360 article-title: Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.07.027 – volume: 77 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0400 article-title: ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival publication-title: Urology doi: 10.1016/j.urology.2010.09.022 – volume: 26 start-page: 851 year: 2006 ident: 10.1016/j.eururo.2013.12.003_bib0305 article-title: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas publication-title: Oncogene doi: 10.1038/sj.onc.1209846 – volume: 474 start-page: 390 year: 2011 ident: 10.1016/j.eururo.2013.12.003_bib0110 article-title: Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA publication-title: Nature doi: 10.1038/nature10006 – volume: 340 start-page: 201 year: 2013 ident: 10.1016/j.eururo.2013.12.003_bib0050 article-title: Beyond microRNA—novel RNAs derived from small non-coding RNA and their implication in cancer publication-title: Cancer Lett doi: 10.1016/j.canlet.2012.11.058 – reference: 24508069 - Eur Urol. 2014 Jun;65(6):1152-3 |
| SSID | ssj0003593 |
| Score | 2.6127198 |
| SecondaryResourceType | review_article |
| Snippet | Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in virtually all... Abstract Context Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate... Context Genomic regions without protein-coding potential give rise to millions of protein-noncoding RNA transcripts (noncoding RNA) that participate in... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1140 |
| SubjectTerms | Beckwith-Wiedemann syndrome Biological and medical sciences Biomarkers, Tumor - genetics Biomarkers, Tumor - urine Bladder cancer Epigenesis, Genetic Female Gene Expression Regulation, Neoplastic - genetics Gynecology. Andrology. Obstetrics Humans Kidney cancer Kidney Neoplasms - diagnosis Kidney Neoplasms - drug therapy Kidney Neoplasms - genetics lncRNA Long noncoding RNA Male Male genital diseases Medical sciences Nephrology. Urinary tract diseases Prostate cancer Prostatic Neoplasms - diagnosis Prostatic Neoplasms - drug therapy Prostatic Neoplasms - genetics Pseudogenes Renal cell carcinoma RNA, Long Noncoding - genetics RNA, Long Noncoding - urine RNA, Small Interfering - therapeutic use Tumors Tumors of the urinary system Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - genetics Urinary tract. Prostate gland Urology Urothelial carcinoma Wilms tumour |
| Title | Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0302283813013249 https://www.clinicalkey.es/playcontent/1-s2.0-S0302283813013249 https://dx.doi.org/10.1016/j.eururo.2013.12.003 https://www.ncbi.nlm.nih.gov/pubmed/24373479 https://www.proquest.com/docview/1532482994 https://www.proquest.com/docview/1544000946 |
| Volume | 65 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCqVQQt_ZNF1U6DHu2pZk2bltl4Zt0iylbSA3Ycty2BDkxbt7yCW_vTO2nAdpm9KjjQbJ408zn615AHyg1gFCSRWYNDMBevwiyJM4D8KiLQeVI6zoRPd4lkxPxOGpPN2ASZ8LQ2GV3vZ3Nr211v7OyGtztJjPRz8QnlS7JUUrjJ9UgpL4hFCE8o9XN2Ee3Bfe5W0aMk_79Lk2xsuum3VDKYARb38K9q2z7runp4t8iUqrum4Xf6ajrVs6eAZbnk-ycbfk57Bh3Qt4fOxPzF_C_tfanbFZ7UxNXop9n43Z3LFvlOyBNHOPfbog29PssdyV7GheOnvJJgSF5hWcHHz-OZkGvl9CYJC0rYKYS5vKrIxMKi1xm4TbJM7iIksTU-LnZ4F8LspkIWwsKysT8k5lpEwsTMVlyF_Dpqud3QZmKot-2wjkJ6FQoSyUjFSY4-4ukGBV0QB4ryZtfDFx6mlxofuosXPdKVeTcnUUUxHSAQTXUouumMYD42X_BnSfKIqmTaO1f0BO_U7OLv3-XOpIL3Gkvoeh25J3YPgPcw7vQOT6AdH_C6RRcgDve8xo3MJ0LpM7W69xMRKnTpEXiL-NEaINA00G8KYD3M0MVJ5KqGznvxf_Fp7glehC4HZhc9Ws7TskW6ti2O6mITwafzmazn4BhBsi3w |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKrVICPUFbGmpK_VIukls59EbXRVty-6qakHiZiWOgxYhZ5XdPXDhtzOTOFBEWxDXxJadyTczX-J5AHyi1gEilrGnk1R76PFzL4vCzPPzphxUhrCiE93xJBoeix8n8mQFBl0uDIVVOtvf2vTGWrsrfSfN_mw67f9GeFLtlgStMH5SifQJPBWovtTG4PPlTZwHd5V3eZOHzJMuf64J8jLLellTDmDAm7-CXe-su_5pfZbNUWpl2-7i33y08UsHL2DDEUq23-75JawY-wqejd2R-Wv4MqrsKZtUVlfkptivyT6bWvaTsj2QZ-6xr-dkfOo9ltmCHU4Lay7YgLBQv4Hjg29Hg6HnGiZ4Glnbwgu5NIlMi0An0hC5ibiJwjTM0yTSBX5_5kjoglTmwoSyNDIi91QEsQ6FLrn0-Sas2sqabWC6NOi4tUCC4ovYl3ksg9jPUL1zZFhl0APeiUlpV02cmlqcqy5s7Ey1wlUkXBWEVIW0B971rFlbTeOe8bJ7A6rLFEXbptDc3zMv_ts8M3cKOleBmuNIdQdEf868hcMHrLl7CyLXD4gEQCCPkj342GFGoQ7TwUxmTbXEzUhcOkFiIP43RogmDjTqwVYLuJsVqD6ViNO3j978B3g-PBqP1Oj75HAH1vCOaOPh3sHqol6a98i8Fvluo1lX8QQkbQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+noncoding+RNA+in+prostate%2C+bladder%2C+and+kidney+cancer&rft.jtitle=European+urology&rft.au=Martens-Uzunova%2C+Elena+S&rft.au=B%C3%B6ttcher%2C+Ren%C3%A9&rft.au=Croce%2C+Carlo+M&rft.au=Jenster%2C+Guido&rft.date=2014-06-01&rft.issn=1873-7560&rft.eissn=1873-7560&rft.volume=65&rft.issue=6&rft.spage=1140&rft_id=info:doi/10.1016%2Fj.eururo.2013.12.003&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03022838%2FS0302283814X00023%2Fcov150h.gif |